Literature DB >> 12789183

Histopathologic findings in lupus erythematosus tumidus: review of 80 patients.

Annegret Kuhn1, Monika Sonntag, Thomas Ruzicka, Percy Lehmann, Mosaad Megahed.   

Abstract

BACKGROUND: In a recent study, we demonstrated that lupus erythematosus (LE) tumidus (LET) is a distinct subset of cutaneous LE (CLE), which is clinically characterized by erythematous, urticaria-like, nonscarring plaques in sun-exposed areas.
OBJECTIVE: Our purpose was to analyze skin biopsy specimens from 80 patients with this disease and to determine whether it could be differentiated from other variants of CLE on histopathologic grounds.
METHODS: Skin biopsy specimens from 53 primary and 38 UVA- and/or UVB-induced lesions of 80 patients with LET were examined and compared with skin biopsy specimens from patients with discoid LE (DLE) and subacute CLE (SCLE).
RESULTS: Specimens from LET lesions showed a characteristic and diagnostic pattern of perivascular and periadnexal cellular infiltrates in the papillary and reticular dermis composed almost entirely of lymphocytes. In some cases, few scattered neutrophils were present. Furthermore, interstitial mucin deposition was observed in all specimens, as confirmed by colloidal iron staining. In contrast to discoid LE and subacute CLE lesions, epidermal atrophy or alteration at the dermoepidermal junction was not detected.
CONCLUSION: Skin lesions of patients with LET present with specific histopathologic features, and the differences compared with subacute CLE and discoid LE further support the concept to consider LET as a separate entity of CLE.

Entities:  

Mesh:

Year:  2003        PMID: 12789183     DOI: 10.1067/mjd.2003.435

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  13 in total

1.  [Topical treatment with tacrolimus in lupus erythematosus tumidus].

Authors:  D Bacman; A Tanbajewa; M Megahed; T Ruzicka; A Kuhn
Journal:  Hautarzt       Date:  2003-10       Impact factor: 0.751

2.  Ustekinumab-induced drug eruption resembling lymphocytic infiltration (of Jessner-Kanof) and lupus erythematosus tumidus.

Authors:  Claudio Guarneri; Maria Lentini; Giovanni Polimeni; Roberta Giuffrida; Serafinella P Cannavò
Journal:  Br J Clin Pharmacol       Date:  2015-12-29       Impact factor: 4.335

3.  [Cutaneous lupus erythematosus. Part 1: clinical manifestations and classification].

Authors:  A Kuhn; K Gensch; S Ständer; G Bonsmann
Journal:  Hautarzt       Date:  2006-03       Impact factor: 0.751

4.  [Extreme photosensitivity since childhood].

Authors:  A Kuhn; S Hanneken; M Megahed; T Ruzicka; N J Neumann
Journal:  Hautarzt       Date:  2006-01       Impact factor: 0.751

5.  [Skin manifestations in lupus erythematosus: clinical aspects and therapy].

Authors:  A Kuhn; V Ruland; G Bonsmann
Journal:  Z Rheumatol       Date:  2011-04       Impact factor: 1.372

6.  Coexistence of tumid lupus erythematosus with systemic lupus erythematosus and discoid lupus erythematosus: a report of two cases of tumid lupus.

Authors:  Jennifer Stead; Catherine Headley; Michael Ioffreda; Carrie Kovarik; Victoria Werth
Journal:  J Clin Rheumatol       Date:  2008-12       Impact factor: 3.517

7.  Cutaneous lupus and the Cutaneous Lupus Erythematosus Disease Area and Severity Index instrument.

Authors:  Rachel S Klein; Pamela A Morganroth; Victoria P Werth
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

8.  Lupus Erythematosus Tumidus Mimicking Primary Cutaneous Marginal Zone B-cell Lymphoma.

Authors:  Megan H Trager; Caroline Ram-Wolff; Jean-David Bouaziz; Maxime Battistella; Marie-Dominique Vignon-Pennamen; Jacqueline Rivet; Pauline Brice; Adèle de Masson; Larisa J Geskin; Martine Bagot; Gabor Dobos
Journal:  Acta Derm Venereol       Date:  2020-08-17       Impact factor: 3.875

9.  Lupus tumidus: a report of two cases.

Authors:  Bianca Pinheiro Bousquet Muylaert; Bruna Backsmann Braga; Eduarda Braga Esteves; Luciana Elisa Barandas Garbelini; Alexandre Ozores Michalany; Jayme de Oliveira
Journal:  An Bras Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.896

10.  Tumid lupus erythematosus: an intriguing dermatopathological connotation treated successfully with topical tacrolimus and hydroxyxhloroquine combination.

Authors:  Prashant Verma; Sonal Sharma; Pravesh Yadav; Chaitanya Namdeo; Garima Mahajan
Journal:  Indian J Dermatol       Date:  2014-03       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.